<DOC>
	<DOCNO>NCT00136435</DOCNO>
	<brief_summary>The purpose study determine safety optimal dose L-asparaginase adult patient acute lymphoblastic leukemia ( ALL ) age 18 50 year .</brief_summary>
	<brief_title>A Study Adults With Untreated Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>This study four treatment phase : 1 ) induction , 2 ) central nervous system therapy , 3 ) intensification , 4 ) continuation . The induction phase last one month eight drug use phase treatment . The drug administer follow : - Prednisone ; day 1-28 : - Vincristine ; day 1 , 8 , 15 , 22 : - Doxorubicin ; day 1 2 : - Methotrexate ; day 3 ; - Leucovorin ; 36 hour methotrexate : - Asparaginase ; day 5 : - Intra-thecal Cytarabine ; day 1 , 15 , 29 : - Intra-thecal Methotrexate/Hydrocortisone ; day 15 29 A bone marrow aspirate biopsy obtain day 15 day 29 induction therapy . If day 29 , patient ' bone marrow peripheral blood count complete remission , patient may receive vincristine day 29 , 36 43 . Bone marrow biopsy repeat weekly complete remission document . If patient achieve complete remission day 49 , remove study . Central nervous system ( CNS ) therapy begin immediately end induction therapy . This phase treatment last 3 week . Treatment include series spinal tap instillation anti-leukemia drug . Four spinal tap perform two week period . Anti-leukemia drug also give orally . The drug give follow : Vincristine ; day 1 : Doxorubicin ; day 1 : 6-mercaptopurine ( 6-MP ) ; day 1-14 : Intra-thecal Methotrexate/Cytarabine ; 4 time 2 week . Radiation therapy ( RT ) deliver 10 daily treatment CNS phase therapy . The intensification phase begin soon CNS phase end last approximately 30 week . It consist cycle chemotherapy repeat every 3 week , along asparaginase administer weekly . The drug give follow : Vincristine ; day 1 : Dexamethasone ; day 1-5 : 6-MP ; day 1-14 : Doxorubicin ; day 1 : Asparaginase ; weekly : Methotrexate ; weekly : Intra-thecal Hydrocortisone/Methotrexate/cytarabine ; every 18 week . The continuation phase treatment begin intensification phase . It consist cycle chemotherapy repeat every three week last patient remission two year . The drug give : Vincristine ; day 1 : Prednisone Dexamethasone ; day 1-5 : 6-MP ; day 1-14 : Methotrexate ; weekly : Intra-thecal Methotrexate/Cytarabine/Hydrocortisone : every 18 week . During study , blood test perform start therapy , day 29 post induction time intra-thecal therapy ( every 18 week ) . Bone marrow biopsy/aspirate do day 15 29 induction , every 6 month completion .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>6-Mercaptopurine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Patients must pathologically document acute lymphoblastic leukemia , exclude mature Bcell ALL . No prior therapy leukemia follow exception : one week steroid ; emergent leukapheresis ; emergency treatment hyperleukocytosis hydroxyurea ; cranial RT CNS leukostasis ( one dose ) ; emergent radiation therapy mediastinum . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 2 . Between age 18 50 year . Uncontrolled active infection . Pregnancy nurse mother . Prior history pancreatitis . Prior history cerebrovascular accident hemorrhage . Evidence infection human immunodeficiency virus . Active psychiatric mental illness making informed consent careful clinical followup unlikely . The treat physician consider relevant medical consideration decide whether protocol appropriate particular patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>ALL</keyword>
	<keyword>acute lymphoblastic leukemia</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>asparaginase</keyword>
</DOC>